| | PLYMOUTH MEETING, Pa., Feb. 28, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony’s management team will participate in the following upcoming investor conferences: Leerink Partners Global Biopharma Conference 2024 - Location: Miami
- Fireside Chat: Monday, March 11, 2024, at 12:40 p.m. ET
Barclays 26th Annual Global Healthcare Conference - Location: Miami
- Fireside Chat: Tuesday, March 12, 2024, at 3:35 p.m. ET
A webcast of the fireside chats will be available on the investor page of Harmony’s website at https://ir.harmonybiosciences.com/. About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com. Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com  View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302073404.html
SOURCE Harmony Biosciences | |
